Continued complete remission after a PML/RAR-alpha+ autograft in acute promyelocytic leukaemia
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 56 (3) , 186-187
- https://doi.org/10.1111/j.1600-0609.1996.tb01342.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapyAmerican Journal of Hematology, 1995
- Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia [see comments]Blood, 1994
- Acute promyelocytic leukemia: from genetics to treatmentBlood, 1994
- Chronic myelogenous leukemia: a concise updateBlood, 1993
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaThe Lancet, 1992
- Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reactionBlood, 1992
- Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.Proceedings of the National Academy of Sciences, 1992
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991